Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2008-08-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Family psychoeducation which sets out to inform families of the nature of the illness is called for so as to demystify the illness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Encouragement on drug compliance
The intervention for the placebo comparator will be encouragement on drug compliance
drug compliance
Mothers and their caregivers will be encouraged to comply with the given medication
Encouragement of drug compliance
Mothers and their caregivers in the placebo comparator will receive an intervention of drug compliance encouragement
Family psychoeducation
The experimental group will receive weekly sessions of psychoeducation for 12 weeks in addition to receiving drug compliance encouragement
Family psychoeducation
The experimental group will receive family psychoeducation for 12 sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
drug compliance
Mothers and their caregivers will be encouraged to comply with the given medication
Encouragement of drug compliance
Mothers and their caregivers in the placebo comparator will receive an intervention of drug compliance encouragement
Family psychoeducation
The experimental group will receive family psychoeducation for 12 sessions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have been admitted to the mental health facility for the current episode.
Exclusion Criteria
* Mothers that do not have caregivers.
* Mothers who are not fluent in the language in which the study will be conducted.
13 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish International Development Cooperation Agency (SIDA)
OTHER_GOV
Makerere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Psychiatry, College of Health Sciences, Makerere University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eija Airaksinen
Role: STUDY_DIRECTOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Makerere University College of Health Sciences
Kampala, , Uganda
Makerere University College of Health Sciences
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Janet Nakigudde
Role: primary
Eija Airaksinen
Role: backup
Janet Nakigudde
Role: primary
Eija Airksinen
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006/HD11/4572U
Identifier Type: -
Identifier Source: org_study_id